Nearly all (92%) had moderate-to-severe asthma. Beyond the inflammatory markers, other prognostic factors in risk of asthma attacks severe enough to require at least 3 days of systemic ...

O nly 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40% of academic pulmonary and allergy clinicians have not ...